
Legend Biotech Corporation (NASDAQ:LEGN) Q4 2024 Earnings Call Transcript
Legend Biotech Corporation (NASDAQ:LEGN) Q4 2024 Earnings Call Transcript March 11, 2025 Legend Biotech Corporation beats earnings expectations. Reported EPS is $0.08, expectations were $-0.39. Operator: Good day, and welcome to the Legend Biotech Fourth …